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Abstract
Endometriosis is characterized by the growth of endometrium-like tissue outside
the uterus, most commonly on the pelvic peritoneum and ovaries. Although it
may be asymptomatic in some women, in others it can cause debilitating pain,
infertility or other symptoms including fatigue. Current research is directed both
at understanding the complex etiology and pathophysiology of the disorder and
at the development of new nonsurgical approaches to therapy that lack the
unwanted side effects of current medical management. Tools for endometriosis
research fall into two broad categories; patient-derived tissues, and fluids (and
cells isolated from these sources) or models based on the use of cells or animals.
In this review, we discuss the literature that has reported data from the use of
these tools in endometriosis research and we highlight the strengths and
weaknesses of each. Although many different models are reported in the
literature, hypothesis-driven research will only be facilitated with careful
experimental design and selection of the most appropriate human tissue from
patients with and without endometriosis and combinations of physiologically
relevant in vitro and in vivo laboratory models.
Abbreviations: c-jun, V-jun avian sarcoma virus 17 oncogene homolog; DRG,
dorsal root ganglia; EP2, prostaglandin E2 receptor; EPHect, Endometriosis
Phenome and Biobanking Hormonization Project; ER, estrogen receptor;
GWAS, genome-wide association studies; HEECs, human endometrial
endothelial cells; hTERT, human telemorase reverse transcriptase; HUVECs,
human umbilical vein endothelial cells; K-ras, V-Ki-ras2 Kirsten rat sarcoma
viral oncogene homolog; L-THP, levo-tetrahydropalmatine; NK, natural killer;
PrkdcSCI, loss-of-function mutation in the mouse homologue of the human
PRKDC (severe immunodeficient mice); TGF-b1, transforming growth factor
b1; TIMP-1, tissue inhibitor of matrix metalloproteinase 1; WERF, World
Endometriosis Research Foundation.
Introduction
Endometriosis is characterized by the growth of endome-
trium-like tissue outside the uterus, most commonly on
the pelvic peritoneum and ovaries (1). The presence of
ectopic endometrial deposits (lesions) in the peritoneal
cavity are thought to cause the defining symptoms of
endometriosis, which are debilitating pelvic pain and
infertility. Hence, these multicellular tissue deposits
Key Message
Due to its complex etiology and pathophysiology,
endometriosis research requires careful selection of
appropriate in vitro and in vivo models that, in com-
bination with the use of well-characterized human
tissue can enhance the identification of anxiously
awaited new therapies.
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impact at least two biological systems; the nervous system
and the reproductive system (Figure 1).
To identify new means of treating the symptoms of
endometriosis, it is critical to understand the complex
pathophysiology of the condition. However, not only are
there multiple theories on the origin of endometriosis
(retrograde menstruation/transplantation, metaplasia),
there are many different proposed theories on its patho-
genesis (e.g. genetics, immune response, environment).
Hence, there are multiple considerations and end points
to consider during the design of experiments aimed at
identifying potential therapeutic targets for endometriosis.
Tools for endometriosis research fall into two broad cate-
gories: patient-derived tissue and fluid and cells isolated
from these sources, or models (in vitro and in vivo; Fig-
ure 2). Each have pros and cons and have differing
utilities depending on the research question. In the cur-
rent review, we discuss relevant human tissue resources
and laboratory models for use in endometriosis research
and we highlight the strengths and weaknesses of each.
Material and methods
We conducted a primary computerized literature search
for relevant publications in “PubMed” that related to lab-
oratory models for identifying therapeutic targets for
endometriosis. We searched using the following key
words: endometriosis AND human tissue OR mouse
model OR rat model OR animal model OR in vitro. One
author (EG) selected relevant abstracts and the full texts
were obtained. EG reviewed studies that were published
from 2000 to 2016 and although those studies formed the
Figure 1. The presence of endometriosis lesions impacts the reproductive system and the nervous system. Endometriosis lesions present within
the pelvic cavity cause the defining symptoms of the condition, which are infertility and chronic debilitating pelvic pain. Lesions generate an
inflammatory environment, which may have a negative impact on developing oocytes and implanting blastocysts. This inflammation is also
thought to activate nerve fibers that innervate lesions. In addition to disease-specific cellular and molecular changes, extensive lesions and
adhesions can cause distortion of the pelvic organs and nerve compression that may also contribute to fertility problems and pain. Animal models
of endometriosis are required to dissect out specific disease mechanisms that impact on the reproductive and nervous system. [Color figure can
be viewed at wileyonlinelibrary.com]
ª 2017 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd
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basis of our review, some older publications were
included as deemed appropriate for historical but pivotal
models of endometriosis. Reference lists from other pub-
lications were also examined for any relevant studies that
were not extracted from the initial literature search. Arti-
cles were included if they (i) described the use of human
tissue for the identification of novel genetic traits or path-
ways that could represent therapeutic targets for
endometriosis (studies using human tissue were included
only if patients and controls were confirmed via laparo-
scopy to have or not have endometriosis), (ii) described a
unique in vivo rodent model of endometriosis, or (iii)
described relevant in vitro techniques for the study of
endometriosis. This is not a systematic review.
Patient-derived tissue, fluid and cells
The appropriate methodology for the collection
of patient-derived material
The analysis of human samples has provided valuable
advances in our understanding of biological changes asso-
ciated with endometriosis in both the peritoneum and
the endometrium. As yet there are no validated clinical
biomarkers of endometriosis (2), so the reference stan-
dard for diagnosis of the condition is the macroscopic
visualization of lesions during laparoscopy. The procedure
provides clinicians with an opportunity for the collection
of tissue and fluid biospecimens for use in endometriosis
research.
Many centers worldwide have been collecting tissue
and fluids from patients with and without endometriosis
undergoing laparoscopy, as well as surgical and clinical
phenotype data for a range of research purposes. How-
ever, huge variations in the collection of such data and
specimens exist that could limit comparisons in data and
reproducibility of results from different studies. The
World Endometriosis Research Foundation (WERF)
Endometriosis Phenome and Biobanking Harmonization
Project (EPHect) spearheaded a mission to promote the
adoption of internationally agreed standard operating
procedures for tissue and fluid sample collection, process-
ing and storage as well as surgical and clinical phenotype
data collection. The WERF EPHect working group
developed surgical and clinical questionnaires and
evidence-based standard operating procedures that were
published in four concurrent articles (3–6). This stan-
dardization will optimize sample quality, reduce variabil-
ity and enable large-scale cross-centre, epidemiologically
robust endometriosis research. At the time of writing this
review there are 13 registered centers using the WERF
EPHect tools (http://endometriosisfoundation.org/ephec
t/centres-using-werf-ephect-tools/). A list of human bio-
logical specimens being used in endometriosis research is
provided in Table 1.
Lesions vary in their location and invasiveness, biopsies
can therefore be from the ovaries (endometriomas), the
peritoneal lining, or deep infiltrating nodules. This
Figure 2. Research question specific models for the study of endometriosis. Many theories on the pathophysiology and etiology of endometriosis
exist. Hypothesis-driven research will be facilitated with careful experimental design and selection of appropriate human tissue from patients with
and without endometriosis and appropriate combinations of in vitro and in vivo laboratory models. [Color figure can be viewed at
wileyonlinelibrary.com]
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heterogeneous nature of lesion biopsies, presentation of
the condition, disease classification, variation in sample
metadata, and the lack of correlation between perceived
severity of disease and symptomatology can make data
generated in endometriosis studies difficult to interpret.
Standardization of clinical phenotype data collection and
biopsy recovery through WERF EPHect will enable the
generation of more reliable and comparable data. Samples
should also be explicitly characterized and comprehensive
details of sample metadata (cycle stage, disease severity,
pain scores, history of subfertility) should be published
alongside any results using human tissue to ensure trans-
parency of any potential confounding factors.
Appropriate use of experimental controls is critical for
human tissue data to be informative. Peritoneum and
endometrium control samples should be included in
studies that analyze gene expression in endometriosis
lesions (particularly homogenized samples), because
lesion biopsies are often contaminated with surrounding
peritoneal tissue and in these cases it should be included
as a control. It is not sufficient to compare gene expres-
sion in endometriosis lesions only to the endometrium or
peritoneum alone. It is not entirely necessary to include
peritoneal controls in immunohistochemical analysis of
particular cell types, for example, because it is easy to dis-
tinguish the lesion boundary from surrounding peri-
toneum. Biopsies of peritoneum from sites adjacent and
distal to lesions in patients with endometriosis and from
sites prone to endometriosis in patients without the con-
dition (Figure 3) also provides useful biological informa-
tion when analyzed as additional controls within an
experiment. Menstrual cycle phase is also known to have
obvious impacts on peritoneal fluid concentration (7)
and composition, and a profound impact on endometrial
(8), and likely also endometriosis lesion, gene expression.
Exogenous hormones can also modulate gene expression
in these samples. For example, oral contraceptive use
increases the expression of cyclooxygenase-2 in the
eutopic and ectopic endometrium of women with
endometriosis (9). Stromal cells isolated from ovarian
endometriomas exhibit increased expression of aromatase,
estradiol 17b-dehydrogenase 1, steroid sulfatase and estro-
gen sulfotransferase (10). Whether these gene expression
changes are maintained when cells are isolated and cul-
tured is uncertain because the majority of published stud-
ies use cells derived from patients that have not had
exogenous hormone treatment 3–6 months before laparo-
scopy. Access to true control samples collected from fer-
tile patients with no pain and no endometriosis is often
limited due to the fact that few women undergo laparo-
scopy (or endometrial biopsy) without symptoms (decline
in laparoscopic sterilization). As women may exhibit no
symptoms even though they have lesions, consistent with
endometriosis detected at laparoscopy, caution is neces-
sary in defining “control” samples.
Below we discuss a limited number of key studies that
have significantly enhanced our understanding of
endometriosis and also provide examples of identification
of genes or pathways that could be targets for therapeutic
intervention.
Identification of genes associated with
endometriosis, gene expression trends, and novel
pathways
Microarray transcriptomic studies in combination with
pathway analysis have yielded informative results on bio-
logical changes taking place in the eutopic endometrium
of women with endometriosis; Burney et al. demonstrated
a dysregulation of the proliferative to secretory transition
in women with endometriosis. In secretory phase endo-
metrium of women with endometriosis the authors iden-
tified persistent expression of genes associated with DNA
synthesis and cellular mitosis and decreased expression of
progesterone-regulated genes, suggestive of a “proges-
terone-resistant” phenotype (11).
Figure 3. Peritoneal and endometriosis lesions collected at time of surgery. Taking biopsies of peritoneum from sites adjacent and distal to
lesions in patients with endometriosis, and from sites prone to endometriosis in patients without the condition provides useful biological
information when analyzed as additional controls within an experiment. [Color figure can be viewed at wileyonlinelibrary.com]
ª 2017 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd
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Genome-wide association studies (GWAS) performed
on DNA extracted from blood or saliva, in combination
with replication studies, have been hugely informative in
the identification of genetic loci associated with
endometriosis risk and associations with other genetic
traits (12,13). GWAS studies provide an opportunity for
identifying new drug targets for endometriosis; genes dis-
covered using this approach can be investigated for their
ability to be targeted by small molecule inhibitors and
therapeutic antibodies or protein therapeutics. For exam-
ple 155 of 991 genes implicated in disease from GWAS
(15.6%) have an associated drug project in development
(12). The implementation of WERF EPHect standard
operating procedures for the collection, processing, and
storage of tissue and biofluid specimens will enhance such
large-scale cross-centre collaboration, such as GWAS. Val-
idation of results generated in GWAS studies remains a
challenge, as does exploring the mechanistic relevance of
identified genes.
Analysis of cytokine profiles of peritoneal fluid samples
identified a subset of patients with a shared consensus
signature of elevated cytokines associated with macro-
phage infiltration and activation. Bioinformatics analysis
identified an enrichment of V-jun avian sarcoma virus 17
oncogene homolog (c-jun), FBJ murine osteosarcoma
viral oncogene homolog (c-fos) and activator protein 1
(AP-1) transcription factor binding sites among the mea-
sured consensus cytokine signature. Subsequent inhibition
of upstream kinases of c-jun resulted in an attenuation of
cytokine expression by macrophages isolated from peri-
toneal fluid from women with endometriosis (14),
suggestive of a novel therapeutic strategy for limiting
inflammatory mechanisms that drive endometriosis.
How studies on cells derived from patient tissues/
fluids have informed our understanding of the
pathophysiology of the disorder
In a study from our group, gene expression analysis per-
formed on human endometriosis lesions compared with
endometrium and peritoneum revealed an upregulation
of the axonal guidance molecule SLIT3 in lesions (15). In
this same study immunofluorescence performed on
human endometriosis lesions indicated that endothelial
cells lining the blood vessels of lesions express estrogen
receptor b (ERb) and not ERa, and that blood vessels
and nerves are found in close proximity in lesions. These
findings informed in vitro and in vivo studies exploring
ER regulation of Slits in blood vessel–nerve crosstalk in
endometriosis (15). In another study from our team,
analysis of peritoneal fluid revealed increased levels of
transforming growth factor b1 (TGF-b1) and lactate in
women with endometriosis, and an increase in glycolysis-
related genes (16). This informed investigation of TGF-b1
regulation of glycolysis genes and lactate levels in peri-
toneal mesothelial cells from women with and without
endometriosis and led to the hypothesis that the “War-
burg effect” (a high rate of glycolysis and lactic acid fer-
mentation) seen in tumorigenesis is a key contributor to
the pathophysiology of endometriosis and may be modu-
lated by TGF-b (16). These two studies emphasize the
power of integrated studies that use a number of different
Figure 4. Endometriosis lesions are multicellular tissue deposits. Typical endometriosis lesions contain endometrioid glandular structures (made
up of epithelial cells) and stromal cells, similar to the eutopic endometrium. Lesions become vascularized, innervated and infiltrated by immune
cells such as macrophages, mast cells and natural killer cells. Isolation of specific cell types from lesions is difficult due to the limited amount of
tissue available from biopsies. In most cases the exploration of cellular interactions must be recreated using cell models and disease-specific
effects on physiology must be modeled in vivo. [Color figure can be viewed at wileyonlinelibrary.com]
ª 2017 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd
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models to explore hypothesis-driven endometriosis
research.
Endometriosis lesions are complex multicellular tissue
deposits (Figure 4). The hallmarks of an endometriosis
lesion are the presence of endometrioid epithelial and
stromal cells that resemble the cellular organization of the
eutopic endometrium. These lesions are highly vascular-
ized and we now know that they are innervated, enabling
a dialogue between the lesion microenvironment and the
nervous system. Immune cells including macrophages,
mast cells, T and B lymphocytes and natural killer (NK)
cells are also present within lesions and contribute to the
inflammatory microenvironment of the lesion. The pelvic
peritoneum may also play an important role in the estab-
lishment and progression of endometriosis by providing a
surface for the attachment of endometrial fragments.
Hence, many different cellular interactions can take place
within a lesion and appropriate cells are required for the
study of these interactions. To complement studies on
intact tissue biopsies a number of studies have also
focused on analysis of different cell types isolated from
patient biopsies.
Eutopic endometrium. Non-cancerous epithelial cells
are difficult to propagate from primary tissue due to their
short lifespan and usually enter senescence after 2 weeks
in culture. For this reason, only a limited number of
studies use epithelial cells from patients with endometrio-
sis. Those that have, indicate altered gene expression and
enhanced migratory abilities in epithelial cells isolated
from patients with endometriosis (17). Stromal cells are
much easier to isolate and propagate from primary tissue
and many studies have used stromal cells isolated from
the eutopic endometrium from patients with and without
endometriosis undergoing laparoscopy. Endometrial stro-
mal cells may be induced to decidualize in vitro using
progesterone and cAMP. This approach has been used as
a model for studying the potential effects of endometrio-
sis on endometrial receptivity and differences in gene
expression in cells from women with and without
endometriosis. For example, decreased Notch signaling
and connexin 43 expression identified in the endome-
trium of women with endometriosis have been implicated
in impaired decidualization using eutopic stromal cells
(18,19). Immune cells resident in the eutopic endome-
trium of patients may also be isolated with flow cytome-
try. For example uterine NK cells have been analyzed
using flow cytometry and found to exhibit decreased
levels of killer cell inhibitory receptors (20). Increased
levels of uterine NK progenitor cells have also been iden-
tified with flow cytometry in the eutopic endometrium
and are thought to contribute to endometriosis-associated
infertility (21).
Ectopic endometrium. Epithelial cells have been iso-
lated from lesion biopsies and used to explore the effect
of inhibition of the Wnt/b-catenin pathway on gene
expression and the functional end points proliferation,
migration and invasion (22). The very limited amount of
epithelial cells that can be recovered from ectopic endo-
metrium means multiple experiments cannot be per-
formed from cells isolated from one patient and large
patient numbers are required for a study. Primary stro-
mal cells isolated from endometriosis lesions have also
been used in a number of studies to demonstrate for
example, that these cells also have an increased migration
and invasion ability (23).
Peritoneum. In women with endometriosis the pheno-
type of the mesothelial cells that line the peritoneal cavity
has been reported to be altered, such that ectopic
endometrial cells are more likely to attach and invade
underlying structures (24). Primary human peritoneal
mesothelial cells can be isolated during laparoscopic sur-
gery by gentle brushing of the pelvic mesothelium using a
specialized brush, the cells can then be dislodged and
established in culture (16). These cell types have been
used in studies that shed new light on the role of the
mesothelial cell in endometriosis pathophysiology includ-
ing a Warburg-like metabolic reprogramming (16,25–27).
Peritoneal mesothelial cells have also been used in a co-
culture model to simulate interactions between endome-
trial stromal cells and human peritoneal mesothelial cells
in normal and pathophysiological states (28).
Immune cells derived from peritoneal fluid or
peripheral blood. The peritoneal fluid is an incredibly
useful resource for the study of the role played by
immune cells in the etiology of endometriosis. T and B
lymphocytes, NK cells and macrophages (14) isolated
from the peritoneal fluid of women with and without
endometriosis have been analyzed in a number of studies
(29–31). The presence of endometriosis has also been
hypothesized to effect immune profiles systemically; T, B
and NK cells isolated from the peripheral blood from
women with endometriosis have also been analyzed (29–
31).
In vitro and in vivo model systems
In vitro models
The number of cells that can be isolated from lesions is
limiting for many studies. Additionally, nerves for exam-
ple, cannot be isolated from biopsies and for these rea-
sons cell models are required. Primary patient-derived
ª 2017 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd
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cells or cell models provide a limited “snap shot” of gene
expression or cell function and at best can be used to
provide some information on cell–cell interaction when
used in co-culture or three-dimensional culture systems.
Epithelial and stromal cells. The limited number of
cells that can be isolated from endometriosis lesions is
often the reason that many researchers decide to use cell
lines. Normal human endometrial epithelial cells have
been immortalized using human papillomavirus and
human telemorase reverse transcriptase (hTERT) (32)
and used as a control cell in a number of endometriosis
studies. Purified epithelial cells isolated from ovarian
endometriomas (E’mosis1 and 2) have also been immor-
talized by combined transfection of human cyclinD1,
cyclin-dependent kinase 4 (cdk4) and human telomerase
reverse transcriptase (hTERT) (33). Another widely used
endometriotic epithelial cell line (12Z) was first estab-
lished from an active peritoneal lesion (34). As each of
these cell lines is generated from individual patients, it
cannot be assumed that results obtained from their inter-
rogation are a true representation of endometriotic
epithelial cells. However, they are useful for the analysis
of signaling pathways or functional studies investigating
invasion, migration and proliferation that may need more
cells than can be isolated from primary tissue. The ecto-
pic stromal cell line 22B (derived from an active red peri-
toneal lesion) has been used in a number of studies
(34,35) but poses the same limitation as the ectopic
epithelial cell line discussed above.
Mesothelial cells. The humen pleural cavity mesothelial
cell line MeT-5A has also been used in endometriosis
studies and is thought to mirror the phenotype of pri-
mary human peritoneal mesothelial cells. A peritoneal
mesothelial cell line has been established through trans-
fection with simian vacuolating virus 40 TAg (SV40 T)
antigen (36). Peritoneal mesothelial cell line (LP9) is a
commercially available peritoneal mesothelial cell line that
has been used in a limited number of endometriosis stud-
ies (37). Primary mesothelial cells derived from different
locations and cell lines are thought to have a similar phe-
notype to peritoneal mesothelial cells. However, as with
most cell lines they are not useful for exploring disease-
specific phenotype.
Immune cells. Although peritoneal fluid is readily
accessible during laparoscopy, analysis of its immune cells
may not represent immune cell phenotypes present within
endometriosis lesions. For example, tissue-resident
macrophages are known to have a different phenotype to
peritoneal fluid macrophages. Peripheral blood mono-
cyte-derived macrophages may be plated and activated
using different cytokines and estradiol to generate a phe-
notype similar to an endometriosis macrophage (38), this
model is useful when large numbers of cells are required
for gene expression and functional studies. Due to the
small size of lesion biopsy material, flow cytometry for
the isolation of lesion-resident immune cells is extremely
difficult and limits any manipulation of these cells
ex vivo.
Nerve fibers. Mechsners’ group analyzed a chicken dor-
sal root ganglia (DRG) explant model to explore the
effects of peritoneal fluid on neurite outgrowth (39).
DRG are thought to contain predominantly sensory neu-
rons, and this group were also able to recover sympa-
thetic ganglia to aid their studies showing an imbalance
between sensory and sympathetic innervation in lesions
of women with endometriosis; incubation of chicken
DRG with peritoneal fluid from women with endometrio-
sis resulted in increased neurite outgrowth from sensory
ganglia and a decrease in neurite outgrowth from sympa-
thetic ganglia (40). Rat DRG explants have also been used
to explore both endothelial cell–nerve and macrophage–
nerve crosstalk to explore the mechanisms underlying
endometriosis-associated pain (15,38), whereas dissociated
rat DRG neurons have been used in gene expression stud-
ies (15,38). Human embryonic stem cells can be rapidly
converted into sensory neurons with a nociceptor-like
phenotype using small molecule inhibitors (41), this tech-
nique holds great potential as a platform for exploring
peripheral nerve mechanisms in endometriosis. Recently,
this model has been used to explore ER-mediated expres-
sion of nociceptive ion channels (42).
Endothelial cells. Ectopic endometrial fragments must
acquire a vasculature to survive and form a lesion; more-
over, invading immune cells extravasate from the blood-
stream into vascularized lesions to contribute to the
inflammatory environment of the lesion, hence neovascu-
larization/angiogenesis are an important process in the
etiology of endometriosis. Anti-angiogenic drugs are
being explored as a potential therapy for endometriosis
and endothelial cells are used as a model in endometriosis
research. To our knowledge there are no studies docu-
menting the isolation and propagation of endothelial cells
from endometriotic lesions. Endothelial cells can be iso-
lated from the human endometrium (43) and have been
immortalized and shown to retain their phenotype in cul-
ture (44). These human endometrial endothelial cells
(HEECs) have been used in endometriosis research
exploring the crosstalk between endothelial cells and
nerve fibers; conditioned media from rat DRG can
enhance network formation by HEECs (15). Human
umbilical vein endothelial cells (HUVECs) are also often
ª 2017 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd
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used as an endothelial cell model for angiogenesis
research. However, endothelial cells are known to have
vascular-bed-specific responses and HUVECs are isolated
from macrovessels compared with microvessels like the
endometrial endothelial cells. To this end, HUVECs
express several extracellular matrix proteins not expressed
in HEECs (43).
Three-dimensional in vitro models in
endometriosis research
Co-culture models can be used to assess the effect of one
cell type on another (45). Three-dimensional (3D) cell
culture models are reported to mirror phenotype and
gene expression in vivo more closely than 2D culture sys-
tems, moreover 3D culture offers an opportunity to
explore the interactions between different cells relevant to
endometriosis research. Ex vivo culture of human
endometrial tissue in a 3D fibrin matrix has been shown
to mimic the early stages of endometriosis invasion, gland
and stroma formation and sprouting of new vessels (46).
Recent advances in microfabrication technologies have
enabled researchers to more closely mirror physiological
interactions and microenvironment of human tissue.
“Organs-on-Chips” (47) use a microfluidic system to
reconstitute the organ architecture on the chip. The
major cellular constituents of the endometrium are iso-
lated and then reassembled in microfluidic devices that
are fabricated with biocompatible materials and hydro-
gels. These devices individually compartmentalize each
cell type in independent chambers and allow imaging.
Furthermore, “organ” to “organ” communication can be
assessed by connecting two “organ-on-chips”; in the
review the authors suggest that placing a “liver-on-chip”
upstream of an “endometrium-on-chip” has the potential
to assess the effect of metabolites on endometrial function
(48). This approach could potentially revolutionize our
in vitro studies and allow identification of novel targets
and testing of potential therapeutics in endometriosis
without the need for animal models of disease.
Animal models
In vivo models can be used to investigate the effect of the
presence of endometriosis lesions on functional outcomes
such as fertility or pain that requires behavior analysis.
Moreover, in vivo models allow the preclinical testing of
potential therapies that are required for us to move
towards anxiously awaited new therapeutic options. Spon-
taneous endometriosis occurs only in humans and some
primates such as rhesus monkeys and baboons (49), that
have menstrual cycles. Non-human primates offer the
most physiologically relevant animal model of
endometriosis in terms of phylogeny and reproductive
anatomy but their uses are limited due to cost and ethical
concerns. The study of endometriosis in the Baboon is an
attractive option for a number of reasons, including non-
invasive cycle monitoring, continuous breeding, collection
of naturally occurring peritoneal fluid, spontaneous retro-
grade menstruation and human-like minimal to severe
endometriosis. Research in baboons has been pivotal in
our understanding on some key pathophysiological fea-
tures of endometriosis, which have been reviewed else-
where (50). Rodent models of endometriosis have been
developed and as they offer a more tangible laboratory
model of the disease they will be the focus of this section
of the review.
Rat. The rat autologous model as developed by Vernon
and Wilson in 1985 (51) uses intact animals allowing the
exploration of the effects of endometriosis on fertility and
fecundity and has been used historically to demonstrate
that ectopic endometrium is associated with an increased
frequency of luteinized unruptured follicles and altered
follicular development (52). This model was modified
slightly by Berkley et al. (53), who sutured small pieces of
uterus not only to the mesenteric cascade but also onto
the abdomen and ovary to more closely mirror the distri-
bution of lesions in women. Berkley’s group was the first
to use the rat model to explore the association between
endometriosis and increased pelvic nociception and
demonstrated that the rats had vaginal hyperalgesia in-
line with viscera–visceral referred hyperalgesia that could
be suggestive of altered pain responses at the central ner-
vous system level (53). This study preceded a number of
pivotal publications that broke new ground on our
understanding of pain mechanisms in endometriosis; the
group were the first to demonstrate that lesions are
actively innervated (54), they demonstrated that
endometriosis influences pain behaviors induced by uret-
eral calculosis (55) again exploring the phenomenon of
“viscera–visceral” hyperalgesia, and that estradiol levels
modulate endometriosis-induced vaginal nociception
(56,57), innervation, vascularization and growth factor
content of lesions (58). Much of our understanding of
pain mechanisms in endometriosis has stemmed from
these publications.
In a refinement of the autotransplant model, MRI was
used to serially and noninvasively monitor lesion growth
and to obtain lesion volumes allowing for a reduction in
animal usage (59). Subsequently, the rat model has been
used in many studies as a test-bed for potential therapeu-
tics including melatonin (60), doxycycline (61), Etaner-
cept (tumor necrosis factor a antibody) (62), and gene
therapy delivered via polymeric micelles (63). The natu-
ral, mixed dopamine receptor antagonist Levo-
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tetrahydropalmatine (L-THP) was shown to reduce lesion
growth and to alleviate generalized hyperalgesia (64). This
list is certainly not exhaustive and we apologize to
authors of the studies we cannot cite due to reference
limitations. Zhao et al. also demonstrated an up-regula-
tion of gene expression in dorsal root ganglia that was
associated with increased nociception and this was atten-
uated by L-THP treatment (64). The rat model has also
been used to demonstrate that tissue inhibitor of matrix
metalloproteinase 1 (TIMP1) secreted from ectopic uter-
ine tissue explants resulted in poorer embryo quality and
deleterious effects on ovulation (65) and the authors sug-
gested that novel TIMP-1-modulating therapies may be
developed to alleviate infertility in women with
endometriosis.
Recently, the rat has been used to explore pain mecha-
nisms using innovative techniques. Dmitrieva et al. used
telemetric assessment to record visceromotor responses
induced by vaginal distention, allowing observer-indepen-
dent recording (66). In a unique take on the rat model,
Alvarez et al. grafted autologous uterine tissue onto the
gastrocnemius muscle allowing for in vivo electrophysio-
logical recordings from sensory neurons innervating the
graft and the exploration of agents injected directly into
the graft (67). Uterine fragments have also been grafted
onto the sciatic nerve to mimic neuropathic pain that
might arise in endometriosis (68). Although these studies
allow in-depth mechanistic studies on innervating periph-
eral nerves, this model lacks authentic interactions
between peritoneum and ectopic endometrium and does
not allow physiologically relevant exploration of spinal
cord engagement and vicera–visceral hyperalegsia result-
ing from convergent neurons. For example, using the
Vernon and Wilson model, Chen et al. elegantly showed
pelvic organ cross-sensitization mediated via p38 in the
rostral ventromedial medulla of the spinal cord (69).
A number of studies evaluating the validity of the rat
as a model of endometriosis have analyzed the gene
expression profiles of ectopic tissue deposits in the rat
with the aim of comparing them to endometriosis lesions
in women. Many common pathways were identified
including the inflammatory response, angiogenesis, extra-
cellular matrix re-modeling and wound healing (70–72).
Although the rat model replicates certain aspects of the
disease, all of the modifications discussed above rely on
the suturing of uterine fragments (endometrium plus
myometrium) onto different sites and do not truly simu-
late dissemination of tissue into the peritoneum and for-
mation of lesions from shed endometrial tissue. One
study explored the use of fibrin glue and found less local
inflammation and fewer adhesions at the site of the graft
(73) but again this study used full thickness uterine frag-
ments. An obvious limitation of using the rat model is
the low number of commercially available animals engi-
neered to have genetic manipulations. In this respect
mouse models clearly have an advantage over the rat
model.
Mouse. Since the publication of the initial autologous
mouse model of endometriosis (74), which was based on




Humanized mouse model of endometriosis. Human tissue
can be manipulated before xenografting
Uses immunodeficient mice – cannot analyze full immune
cell complement. Usually grafted subcutaneously – does not





Bypasses problems in accessing tissue and variability of
patient material. Used for pain studies
Immunodeficient mice. Not a true recapitulation of an
endometriosis lesion
Autologous No rejection response and good for analysis of immune cell
contribution




Easy to localize lesions and measure regression in drug
treatment studies. Induced in intact mice – useful for
studies on fertility. Genetic manipulation of donor or host




Immunocompetent recipient mice. Genetic manipulation of
donor or host
Uses ovariectomy and supraphysiological levels of estradiol.
Difficult to localize all lesions unless reporter mice used as






Lesions phenocopy those recovered from women. Mirrors
process of retrograde menstruation. Mice exhibit changes
in sensory behavior and molecular changes in nervous
system
Uses ovariectomy and supraphysiological levels of estradiol.
Difficult to localize all lesions unless reporter mice used as
donors or labeling of tissue
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the rat model described by Vernon and Wilson, many
adaptations and refinements have been published (sum-
marized in Table 2). Using mice to model endometriosis
has the added benefit of the wide availability of geneti-
cally engineered animals that express ubiquitous or cell-
specific fluorescent proteins to track cells or monitor
explants as well as conditional or constitutive gene dele-
tions to aid in studies investigating gene function.
Human tissue xenografts—The availability of mice
homozygous for the PrkdcSCID (severe combined immun-
odeficient mice) or mice with a mutation in the forkhead
box protein N1 (FOXN1) gene (Nude mice; athymic with
greatly reduced number of T cells) allows human endo-
metrium to be xenografted either subcutaneously (75) or
intraperitoneally (76) to generate humanized models of
endometriosis because the mice do not mount a rejection
response. This approach is very useful for determining
in vivo how a “human” lesion would respond to a treat-
ment and for elegantly determining cells originating from
endometrial tissue vs. peritoneum/mesothelium (77).
Because these animals are immunocompromised, injec-
tion of endometrial tissue into the peritoneum results in
the formation of lesions and the tissue does not require
suturing. Human endometrial tissue can also be manipu-
lated in vitro before xenografting into the host (78). An
alternative heterologous model uses human immortalized
endometriosis epithelial and stromal cells that are re-sus-
pended in matrigel and xenografted intraperitoneally into
ovariectomized, estradiol-supplemented nude mice (79).
However, lesions that form using this model cannot truly
recapitulate the histological appearance of typical
endometriosis lesions because they are not intact tissue
fragments. These heterologous models limit the analysis
of the host immune response to ectopic tissue; the
inflammatory response being a key area for exploration of
the pathophysiology of endometriosis.
Syngeneic mouse models—Syngeneic models of
endometriosis bypass the limitation of the heterologous
models and allow full analysis of the immune system. It
is still unknown if the immunological perturbation
observed in women with endometriosis is a fundamental
defect of the immune system or a consequence of
endometrial tissue at ectopic sites. Using a syngeneic
model, induction of endometriosis was shown to inhibit
spleen leucocyte function (80), which has clear implica-
tions for immunological therapies.
A number of variations of the syngeneic model exist;
donor uterine tissue (full thickness or endometrial frag-
ments only) are sutured onto the peritoneal lining or
injected into the peritoneal space using a syringe or small
laparotomic incision (81). Donor material is usually
collected at estrous or following pregnant mare serum
gonadotropin (82) or estradiol priming (83). A recently
published study from our group used mouse “menstrual”
donor endometrial tissue to inoculate syngeneic recipients
(84). “Menstrual” endometrium was generated by hor-
monal manipulation using subcutaneous estradiol injec-
tions and a progesterone implant plus a decidualization
stimulus to mimic the human menstrual cycle (85). Fol-
lowing progesterone withdrawal (4 h) decidualized bleed-
ing endometrium was recovered and used to inoculate
ovariectomized and estradiol-supplemented recipients.
Lesions were recovered after 21 days that mirrored
human lesions in histological appearance, vascularization,
innervation and influx of macrophages (15,38,84). More
recently we have used our model to demonstrate that
mice with endometriosis lesions exhibit robust changes in
sensory behavior (both spontaneous and evoked) and ele-
vated cyclooxygenase-2 expression in the spinal cord and
brain indicative of central sensitization (Greaves et al.,
2017, accepted). The model can be used for preclinical
testing of potential therapies for targeting endometriosis-
associated pain; we have demonstrated that a highly selec-
tive prostaglandin E2 receptor (EP2) antagonist could sig-
nificantly attenuate both abdominal and secondary
hyperalgesia.
Interestingly, the spiny mouse (Acomys cahirinus) was
recently found to undergo spontaneous decidualization,
endometrial shedding and bleeding, demonstrating for
the first time menstruation in a rodent (86). Whether this
mouse spontaneously develops endometriosis and its use
in endometriosis research is still to be determined.
A number of studies describe an improvement on ver-
sions of the mouse model of endometriosis to allow non-
invasive monitoring of lesions. In one such study, human
endometrial fragments were transduced with green fluo-
rescent protein, transplanted into nude mice and imaged
through the skin. However, because the adenoviral
expression vector is transient the fluorescence faded by
the third week so longitudinal studies are limited (87).
Another study used donor mice engineered to ubiqui-
tously express luciferase and uterine fragments were
sutured to the peritoneal wall of non-luminescent recipi-
ent mice. Anesthetized mice were injected with luciferin
(intravenously or intraperitoneally) and bioluminescence
was imaged. This approach was used successfully to mon-
itor the efficacy of antiangiogenic therapy (88). The abil-
ity for non-invasive monitoring of lesions is very
desirable for preclinical models of endometriosis.
Spontaneous model of endometriosis—A sponta-
neous model of ovarian endometriosis has also been
described with induced expression of oncogenic K-ras (V-
Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) in
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ovarian surface epithelium resulting in benign epithelial
lesions on the ovary that exhibit a simple endometrioid
glandular structure; however, no associated stroma was
observed (89). This activated K-ras model was modified
by xenografting “menstrual” endometrium expressing
activated K-ras into a subcutaneous pocket on the ventral
abdomen in intact immunocompetent recipients (90).
Many of the published mouse models use ovariec-
tomized mice supplemented with estradiol as this avoids
the natural variations in estradiol in mice during the
estrous cycle, and uniform availability of estradiol (usu-
ally at higher concentrations than in intact mice) is
believed to promote lesion establishment and growth.
This does, however prevent the analysis of how
endometriosis affects fertility. Endometriosis can be
induced in intact mice, but this model uses full thickness
uterine fragments sutured to the peritoneal wall. The
intact model has been used to demonstrate that
endometriosis is associated with decreased oocyte and
embryo quality (91) and is associated with reduced preg-
nancy rate (92). These studies merit further exploration
of the link between fertility and ectopic tissue.
Summary
The etiology of endometriosis is complex. The availability
of human tissue for endometriosis research has provided
informative descriptive data on the disorder, and the
adoption of internationally agreed-on standard operating
procedures for tissue and fluid sample collection (the
EPHect initiative) will significantly advance this research
approach. An additional layer of complexity is disease-
associated epigenetic regulation and studies should be
undertaken on the epigenetic component of endometrio-
sis and chronic pain susceptibility. Genomic approaches
and next-generation sequencing are now more affordable
than ever, making these large-scale studies more achiev-
able. Model systems are required to explore disease-speci-
fic mechanisms and also to validate genomic pathways
discovered using GWAS and other genomic approaches.
The advent and availability of different models for use in
endometriosis research has considerably improved in
recent years; however it is important that the research
question be carefully considered before selection of the
most relevant models. The physiologically relevant men-
struating mouse model of endometriosis also exhibits
robust changes in sensory behavior and molecular alter-
ations in the central nervous system highlighting the
model as particularly promising for the study of pain
mechanisms in endometriosis, which still remain largely
unknown. Reversal of the endometriosis-associated pain
state has also been demonstrated with a highly specific
EP2 receptor antagonist indicating that this model is an
ideal preclinical platform for testing potential therapeutics
for endometriosis-associated pain. Syngeneic mouse mod-
els of endometriosis can be used to easily explore cellular
contributions of donor/host tissue and genetic manipula-
tion can be used to enhance this. The syngeneic model
also has the added benefit of a full immune system, so
they can be used to explore this important aspect of
endometriosis pathophysiology. Many of the published
mouse models of endometriosis can be further improved
by adapting them to allow non-invasive in vivo monitor-
ing of lesion size.
This review has highlighted the use of many different
cell types and models in use for endometriosis research.
Wherever possible, primary cells should be isolated from
patient samples and sample sizes should be selected to
achieve appropriate power. When this is not possible,
models should be chosen with care. Given the hetero-
geneity of patient endometriosis samples, data generated
using cell lines derived from endometriosis tissue must be
interpreted with caution (generated from one patient).
New microfluidic techniques for 3D cell culture hold par-
ticular promise for enhancing in vitro studies.
The real power of these models can be seen when
ex vivo human tissue, in vitro and in vivo techniques are
used in combination to produce high-quality, clinically
relevant data that advances our understanding and identi-
fies possible future therapeutic targets.
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